AW
NNVC icon

Alaethes Wealth’s NanoViricides NNVC Stock Holding History

Alaethes Wealth’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,133
Closed -$4K – 238
2022
Q1 		$4K Hold
2,133
– – ﹤0.01% 264
2021
Q4 		$8K Hold
2,133
– – 0.01% 216
2021
Q3 		$10K Hold
2,133
– – 0.01% 193
2021
Q2 		$10K Buy
+2,133
New +$8.61K 0.01% 188

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Alaethes Wealth's NNVC Position: Q2 2022 in Review

Alaethes Wealth sold out of NanoViricides (NNVC) in Q2 2022, closing a stake of 2,133 shares — an estimated $4K sold.

Alaethes Wealth first reported a position in NNVC in Q2 2021 and held it in 4 quarters. The position peaked at $10K in Q3 2021. 25 funds tracked by Wall St. Rank hold NNVC as of Q2 2022.

  • Alaethes Wealth reported no remaining NanoViricides position as of Q2 2022 after selling out during the quarter.
  • Alaethes Wealth sold 2,133 NanoViricides shares in Q2 2022, an estimated $4K.
  • Alaethes Wealth first reported a position in NanoViricides in Q2 2021 and held it in 4 quarters.
  • Alaethes Wealth's NanoViricides position peaked at $10K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held NanoViricides as of Q2 2022.

Based on Alaethes Wealth's 13F filing for Q2 2022, filed 16 Aug 2022.